Blood clots in the kidneys form through several distinct pathways, and the cause depends largely on which blood vessels are involved. A clot can lodge in a renal vein (carrying blood away from the kidney), a renal artery (carrying blood in), or the tiny vessels within the kidney tissue itself. Nephrotic syndrome and chronic kidney disease are among the most common culprits for venous clots, while heart rhythm disorders and autoimmune conditions more often drive arterial ones. Because the kidney is one of the most heavily perfused organs in the body, receiving roughly a quarter of all cardiac output, it sits at a crossroads for clotting problems that originate elsewhere and for those that begin locally.
Nephrotic Syndrome and Protein Loss
Nephrotic syndrome is one of the most well-documented causes of kidney blood clots, particularly renal vein thrombosis. The condition causes the kidneys to leak large amounts of protein into the urine. Among the proteins lost is antithrombin III, a natural anticoagulant your body relies on to keep clotting in check. During active disease flares, antithrombin III spills into the urine at levels comparable to what normally circulates in the blood, creating a state in which the blood clots far too easily.1PubMed. Antithrombin III (AT III) and fibrinogen levels in nephrotic syndrome in children When nephrotic syndrome goes into remission, the antithrombin III loss stops and levels often rebound, sometimes overshooting normal as the liver compensates.
Not all forms of nephrotic syndrome carry the same clotting risk. The underlying kidney disease matters a great deal. Membranous nephropathy carries the highest rate of blood clots, followed by focal segmental glomerulosclerosis, with IgA nephropathy posing the lowest risk among the major subtypes. In one study of over 1,300 patients with these three conditions, clot rates were clearly highest in the membranous nephropathy group.2PubMed Central. Bilateral Renal Vein Thrombosis in Membranous Nephropathy: Hypoalbuminemia Predictive of Venous Thromboembolism in Nephrotic Syndrome The severity of protein loss also matters: the lower the blood albumin drops, the higher the clotting risk climbs.3Research and Practice in Thrombosis and Haemostasis. Thromboembolism in nephrotic syndrome: controversies and uncertainties
Beyond losing anticoagulant proteins, nephrotic syndrome also shifts other parts of the clotting balance. The liver ramps up production of clot-promoting factors like fibrinogen, and platelets become stickier. The combined effect is a blood chemistry that strongly favors clot formation, particularly in the slow-flowing renal veins where blood naturally pools.
Autoimmune Diseases That Target Blood Vessels
Antiphospholipid syndrome (APS) is an autoimmune condition in which the immune system produces antibodies that attack proteins involved in blood clotting regulation. The kidneys are frequent targets. APS can cause clots in the renal arteries, renal veins, and even the tiny vessels within the kidney tissue itself, a pattern sometimes called APS nephropathy.4PubMed Central. Antiphospholipid Syndrome Nephropathy: From Pathogenesis to Treatment When clots hit the larger renal vessels, the result can be sudden kidney pain and a sharp decline in function. When they affect the microvasculature, damage accumulates more gradually and can silently erode kidney health over months or years.
Lupus adds another layer of risk. People with systemic lupus erythematosus who also carry antiphospholipid antibodies face a particularly high clotting burden, and having a history of lupus nephritis (kidney inflammation from lupus) makes things considerably worse. In one study, about 60% of lupus patients with both antiphospholipid antibodies and prior kidney involvement experienced a clotting event, compared with 30% of those without prior kidney disease.5Arthritis & Rheumatism. History of Lupus Nephritis Is an Independent Risk Factor for Thrombosis in Systemic Lupus Erythematosus Patients with Antiphospholipid Antibodies Further analysis has confirmed that lupus nephritis and Raynaud’s phenomenon independently predict clotting events in these patients, while antimalarial medications like hydroxychloroquine appear to be protective.6PubMed. Lupus nephritis and Raynaud’s phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies
Heart Conditions and Renal Artery Clots
While nephrotic syndrome and autoimmune disease tend to cause venous clots, the renal arteries face a different set of threats. The most common source of an arterial clot in the kidney is actually the heart. Atrial fibrillation, the most widespread heart rhythm disorder, allows blood to pool and form clots in the heart’s upper chambers. These clots can break free, travel through the aorta, and lodge in a renal artery, cutting off blood supply to part or all of the kidney. Other cardiac sources include diseased heart valves and clots that form on damaged heart tissue after a heart attack.7PubMed Central. Acute unilateral renal embolism: a therapeutic challenge
Complete blockage of a renal artery from an embolism is uncommon but can be dramatic. It often presents as sudden, severe flank or back pain that mimics a kidney stone, which sometimes delays the correct diagnosis. In rare cases, trauma can also trigger renal artery clots. Blunt abdominal injuries, even seemingly moderate ones, can tear the inner lining of the renal arteries, leading to dissection and secondary clot formation. One reported case involved bilateral renal artery dissection and kidney infarction after a fall from just one and a half meters.8PubMed Central. An easily misdiagnosed and rare cause of traumatic back pain: bilateral renal infarction caused by traumatic bilateral renal artery dissection
Atherosclerosis, the gradual buildup of fatty plaque inside arteries, offers a slower route to the same problem. As plaque narrows a renal artery, blood flow slows and the risk of a clot forming on the plaque surface rises. A prospective study using ultrasound monitoring found that renal arteries with 60% or greater narrowing had roughly a one-in-ten chance of progressing to complete occlusion within two years.9PubMed. Natural history of atherosclerotic renal artery stenosis: a prospective study with duplex ultrasonography This kind of slow-motion clotting is most common in older adults with widespread vascular disease.
Kidney Cancer and Tumor Thrombus
Renal cell carcinoma, the most common type of kidney cancer, has an unusual tendency to grow directly into blood vessels rather than just compressing them from outside. About 10 to 13% of patients already have tumor thrombus (a mass of cancer cells extending into the renal vein or beyond) at the time of diagnosis.10PubMed Central. Management of inferior vena cava tumor thrombus in locally advanced renal cell carcinoma In a study of 647 patients, about a third of those with tumor thrombus had extension only in the renal vein, while others had clots reaching into the large vein that returns blood to the heart, and some extended above the diaphragm.11PubMed Central. Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma
Tumor thrombus differs from an ordinary blood clot in that it is a living extension of the cancer itself. Surgical removal of both the tumor and the thrombus remains the standard treatment, though laparoscopic approaches are gaining ground as an alternative to open surgery for clots that have not extended too far.12Perm Medical Journal. Comparative analysis of the results of surgical treatment of kidney cancer complicated by tumor thrombosis of renal vein and inferior vena cava of level I–II The presence of tumor thrombus changes the staging and prognosis of the cancer, but it does not automatically mean the disease has spread to other organs.
Clots in the Smallest Vessels
Not all kidney clots involve the large renal artery or vein. Thrombotic microangiopathy (TMA) describes a pattern of clotting in the kidney’s smallest blood vessels, the arterioles and capillaries of the glomeruli. In TMA, the vessel walls thicken, platelet-rich clots form inside the tiny lumens, and blood flow is partially or completely blocked. The trigger in most cases is injury to the endothelial cells that line these vessels.13PubMed. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura
TMA is the shared pathology behind conditions like hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP). HUS is well known in children as a complication of certain bacterial infections, particularly those caused by toxin-producing strains of E. coli, but TMA can also be triggered by medications, pregnancy complications, bone marrow transplantation, and certain genetic defects in the complement system. The kidney bears the brunt of this microvascular damage because its filtration units depend on healthy, intact capillary beds to function. Even when the condition resolves, the scarring left behind in the glomeruli can lead to lasting kidney impairment.
Certain chemotherapy drugs have also been linked to this type of small-vessel clotting. In one early series, five cancer patients who were tumor-free or had minimal residual disease developed TMA with kidney failure after treatment with cisplatin, bleomycin, and a vinca alkaloid. Tissue examination showed widespread intravascular clotting concentrated in the small arteries, arterioles, and glomeruli of the kidneys, suggesting the chemotherapy itself triggered the damage.14Annals of Internal Medicine. Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy
Anatomical Quirks That Set the Stage
Sometimes the architecture of the blood vessels themselves creates the conditions for a clot. In nutcracker syndrome, the left renal vein gets compressed between the aorta and the superior mesenteric artery (or, in a rarer variant, between the aorta and the spine). The resulting pressure buildup slows blood flow through the vein, and stagnant blood is prone to clotting. Left renal vein thrombosis is the most serious complication of nutcracker syndrome.15PubMed Central. Renal Vein Thrombosis Due to Posterior Nutcracker Syndrome
A review of reported cases found that the compression alone may not be sufficient to cause a clot in most people. In nearly all documented cases, nutcracker syndrome combined with another clotting risk factor, such as dehydration, oral contraceptive use, or an inherited clotting tendency, to push the balance toward thrombosis.16Nephrology & Renal Diseases. Nutcracker syndrome complicated by left renal vein thrombosis and resolution with anticoagulation: A case report and review of the literature This “two-hit” pattern is common across many types of kidney clots: an underlying vulnerability that stays silent until a second provocation tips the scales.
Inherited Clotting Tendencies
Genetic factors play a supporting role in many kidney clot cases, even when they are not the primary cause. The most studied inherited clotting disorder is the Factor V Leiden mutation, which makes a protein in the clotting cascade resistant to being switched off. Carrying this mutation raises the baseline risk of venous thrombosis roughly sevenfold, and it has been linked to a heightened risk of renal vein thrombosis, particularly in newborns.17PubMed. Factor V Leiden mutation: potential thrombogenic role in renal vein, dialysis graft and transplant vascular thrombosis
The relationship between inherited mutations and kidney clots is not as straightforward as it might seem, though. A retrospective study specifically examining patients with nephrotic syndrome found that the Factor V Leiden mutation was not more common among those who developed renal vein thrombosis than among those who did not. The researchers concluded that acquired changes in clotting balance from the nephrotic syndrome itself were likely more important than inherited mutations in driving clot risk, and that routine screening for this particular mutation would miss most high-risk patients.18Nephrology Dialysis Transplantation. The factor V Leiden mutation and risk of renal vein thrombosis in patients with nephrotic syndrome This is a useful reminder that having a genetic tendency does not mean it will be the primary driver when an acquired condition is already doing most of the heavy lifting.
What Happens After a Clot Forms
The consequences of a kidney blood clot depend on which vessel is blocked, how completely, and how quickly treatment begins. A sudden arterial occlusion causes kidney infarction, the death of tissue from lack of blood supply. This typically produces sharp flank or back pain, blood in the urine, and sometimes nausea. One of the less intuitive complications is hypertension. When part of the kidney loses its blood supply, the remaining tissue ramps up production of renin, a hormone that drives blood pressure up. In a study of 55 patients with kidney infarction, 30 presented with new acute hypertension, and these patients were more likely to develop dangerously high blood pressure compared with those who had longstanding hypertension before the event.19PubMed. Blood pressure and renal outcomes in patients with kidney infarction and hypertension
In some cases, this post-infarction hypertension becomes resistant to standard treatment. A case report described a 39-year-old man who developed severe, treatment-resistant high blood pressure after a renal infarction caused by fibromuscular dysplasia, a condition in which the walls of medium-sized arteries develop abnormally. Despite multiple blood pressure medications, his hypertension could not be controlled, and organ damage progressed.20PubMed. Resistant hypertension after renal infarction in a man with fibromuscular dysplasia This illustrates why prompt recognition and treatment of kidney artery clots matters beyond just saving kidney tissue.
Renal vein thrombosis, by contrast, tends to develop more gradually in adults and is sometimes found incidentally during imaging for another reason. When it develops slowly, the kidney may form collateral veins that partially compensate for the blocked drainage. Acute renal vein thrombosis can still cause sudden pain, swelling of the kidney, and a rapid rise in protein levels in the urine. In patients with nephrotic syndrome, it can be difficult to tell whether the venous clot is a cause of worsening kidney function or a consequence of it, because the two conditions feed each other.
How Kidney Clots Are Found
CT angiography, a contrast-enhanced scan that visualizes blood vessels in detail, is generally considered the best imaging tool for diagnosing both renal artery and renal vein clots. It can show the location and extent of a clot, reveal whether kidney tissue has already been damaged, and often identify an underlying cause like tumor growth or anatomical compression. MR angiography serves as an alternative when contrast dye needs to be avoided, and direct catheter-based venography or arteriography is reserved for situations where intervention is planned at the same time as diagnosis.
The challenge with kidney clots is that symptoms often mimic more common conditions. Flank pain, blood in the urine, and elevated blood pressure are also features of kidney stones, pyelonephritis, and various other kidney problems. A high index of suspicion is needed, particularly in patients who have known risk factors like nephrotic syndrome, atrial fibrillation, lupus, or a recent abdominal injury. Many renal vein clots in particular are discovered only after imaging is performed for unexplained worsening of kidney function or a sudden increase in proteinuria.
Hormonal Contraceptives and Other Medication-Related Risks
Hormonal contraceptives are an established risk factor for blood clots throughout the venous system, and the kidneys are no exception, though they account for a small slice of the total burden. In a large national follow-up study of women using hormonal contraception, clots in the vena cava or renal veins made up just under 1% of all venous clotting events, with the vast majority occurring in the leg veins or lungs instead.21BMJ. Hormonal contraception and risk of venous thromboembolism: national follow-up study The risk is low in absolute terms, but it is worth noting because hormonal contraceptive use can combine with other predispositions, like nutcracker syndrome or an inherited clotting mutation, to trigger a clot in someone who might otherwise never have had one.
Neonates face a separate set of medication-related risks. Prolonged use of umbilical artery catheters, common in neonatal intensive care, has been reported to cause renal artery thrombosis, sometimes in association with aortic clots.22PubMed. Endovascular treatment of renal artery thrombosis caused by umbilical artery catheterization The catheter sits in the aorta near the origin of the renal arteries, and any damage to the vessel wall or disruption to blood flow in that area can seed a clot. This is one of the more recognized iatrogenic causes of kidney clots in the youngest patients and is part of why catheter placement and monitoring protocols in neonatal units have been refined over the years.